Ticker Details
Cogent Biosciences, Inc.
IPO Date:	March 26, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.37B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 3.57%
Avg Daily Range (30 D):	$1.00 | 2.53%
Avg Daily Range (90 D):	$0.74 | 2.01%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	1.57M
Avg Daily Volume (90 D):	1.83M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	72

Institutional Trades
Total Institutional Trades:	3,376
Avg Institutional Trade:	$2.38M
Avg Institutional Trade (30 D):	$3.07M
Avg Institutional Trade (90 D):	$3.28M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.92M
Avg Closing Trade (30 D):	$9.68M
Avg Closing Trade (90 D):	$11.9M
Avg Closing Volume:	222.85K

News

Apr 17, 2026 @ 12:00 PM Cogent Biosciences Announces Poster Presentations ... Source: Cogent Biosciences, Inc.

Mar 21, 2026 @ 11:13 PM This $116 Million Buy Joins a 360% Stock Run and S... Source: Jonathan Ponciano

Mar 20, 2026 @ 4:07 PM Biotech Stock Up 372% Gets Sold as New Pick Rises ... Source: Jonathan Ponciano

Mar 16, 2026 @ 4:42 PM Cogent Biosciences Stock Climbs After FDA Accepts ... Source: Vandana Singh

Feb 28, 2026 @ 2:45 PM Cogent Biosciences Highlights Additional Data with... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.52	$-.53	$-.61
Diluted EPS	$-.52	$-.53	$-.61
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-96.41M	$-97.35M	$-102.49M
Operating Income / Loss	$-102.64M	$-103.61M	$-99.49M
Cost of Revenue
Net Cash Flow	$-60.04M	$-70.8M	$186.8M
PE Ratio

Splits
Nov 09, 2020	1:4